OGI vs. CMED, WEED, EMC, ICC, LEAF, MGW, BE, BLO, SL, and MJN
Should you be buying Organigram stock or one of its competitors? The main competitors of Organigram include CanniMed Therapeutics (CMED), Canopy Growth (WEED), Emblem (EMC), ICC Labs (ICC), Leaf Mobile (LEAF), Maple Leaf Green World (MGW), Beleave (BE), Cannabix Technologies (BLO), Supreme Cannabis Company Inc, (SL), and Cronos Group (MJN). These companies are all part of the "cannabis" industry.
Organigram vs. Its Competitors
Organigram (TSE:OGI) and CanniMed Therapeutics (TSE:CMED) are both small-cap cannabis companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation, dividends and media sentiment.
CanniMed Therapeutics has a net margin of 0.00% compared to Organigram's net margin of -31.69%. CanniMed Therapeutics' return on equity of 0.00% beat Organigram's return on equity.
Organigram currently has a consensus target price of C$3.33, indicating a potential upside of 25.00%. Given Organigram's stronger consensus rating and higher possible upside, research analysts clearly believe Organigram is more favorable than CanniMed Therapeutics.
4.0% of Organigram shares are owned by institutional investors. 31.3% of Organigram shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, Organigram had 1 more articles in the media than CanniMed Therapeutics. MarketBeat recorded 1 mentions for Organigram and 0 mentions for CanniMed Therapeutics. Organigram's average media sentiment score of 0.00 equaled CanniMed Therapeutics'average media sentiment score.
CanniMed Therapeutics has lower revenue, but higher earnings than Organigram.
Summary
Organigram beats CanniMed Therapeutics on 7 of the 10 factors compared between the two stocks.
Get Organigram News Delivered to You Automatically
Sign up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Organigram Competitors List
Related Companies and Tools
This page (TSE:OGI) was last updated on 10/14/2025 by MarketBeat.com Staff